Antibiotics | Xconomy

Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in

Entry	Blogger	Date ▴	Location
Targanta Cuts 75 Percent of Staff	Wade Roush	12/18/08	Boston
FDA Declines Approval of Targanta Antibiotic	Ryan McBride	12/09/08	Boston
Rib-X Reveals “Positive” Antibiotic Data	Ryan McBride	12/08/08	Boston
Optimer Sharpens Up Commercial Game Plan, After “C.Diff” Drug Success	Luke Timmerman	12/05/08	San Diego
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter	Luke Timmerman	11/25/08	Boston
Optimer Shares Skyrocket, as Drug Halts Deadly Bacterial Infection in Trial	Luke Timmerman	11/10/08	San Diego
Optimer, Developer of Drug For “C. Diff” Bacteria, Awaits Pivotal Results	Luke Timmerman	10/23/08	San Diego
Trius Therapeutics Wins $28M Contract From NIH For Bioterror Antibiotics	Luke Timmerman	10/22/08	San Diego
Trius Therapeutics, Developer of Antibiotic Against MRSA, Taking On Pfizer’s Zyvox	Luke Timmerman	10/20/08	San Diego
Targanta Preps For FDA Advisory Panel on New Antibiotic	Luke Timmerman	10/14/08	Boston
Rib-X Pharma, and Its Lead Antibiotic, Gear Up for Prime Time	Ryan McBride	10/02/08	Boston
Targanta Aims to “Simplifi” Treatment of Deadly Bugs With Single-Shot Antibiotic	Luke Timmerman	09/22/08	Boston
Enanta Pharmaceuticals Starts Clinical Trial of Antibiotic for Drug Resistant Bacteria	Luke Timmerman	09/15/08	Boston
Targanta Antibiotic Shown Effective in Less-Frequent Dose	Luke Timmerman	09/02/08	Boston
Cubist Agrees to Promote AstraZeneca Antibiotic	Luke Timmerman	07/02/08	Boston
TetraPhase Aims to Fill the Antibiotic Pipeline—and its Executive Office	Ken Wilan	10/05/07	Boston
Page 1 of 1

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2008 Xconomy. All rights reserved. Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.

Close

Social Web